Yusuf S - Search Results

1

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.

McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S; INTERHEART study investigators. McQueen MJ, et al. Among authors: yusuf s. Lancet. 2008 Jul 19;372(9634):224-33. doi: 10.1016/S0140-6736(08)61076-4. Lancet. 2008. PMID: 18640459

2

Two decades of progress in preventing vascular disease.

Yusuf S. Yusuf S. Lancet. 2002 Jul 6;360(9326):2-3. doi: 10.1016/S0140-6736(02)09358-3. Lancet. 2002. PMID: 12114031 No abstract available.

3

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation. Lonn E, et al. Among authors: yusuf s. J Am Coll Cardiol. 2002 Aug 21;40(4):693-702. doi: 10.1016/s0735-1097(02)02035-1. J Am Coll Cardiol. 2002. PMID: 12204499 Free article. Clinical Trial.

4

The global epidemic of atherosclerotic cardiovascular disease.

Yusuf S, Ounpuu S, Anand S. Yusuf S, et al. Med Princ Pract. 2002;11 Suppl 2:3-8. doi: 10.1159/000066416. Med Princ Pract. 2002. PMID: 12444305 Free article.

5

Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.

Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Jong P, et al. Among authors: yusuf s. Lancet. 2003 May 31;361(9372):1843-8. doi: 10.1016/S0140-6736(03)13501-5. Lancet. 2003. PMID: 12788569 Clinical Trial.

6

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Yusuf S, et al. Lancet. 2003 Sep 6;362(9386):777-81. doi: 10.1016/S0140-6736(03)14285-7. Lancet. 2003. PMID: 13678871 Clinical Trial.

7

Tackling the growing global burden of atherosclerotic cardiovascular diseases.

Yusuf S, Ounpuu S. Yusuf S, et al. Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):236-9. doi: 10.1097/01.hjr.0000086301.28200.c2. Eur J Cardiovasc Prev Rehabil. 2003. PMID: 14555877 No abstract available.

8

C-reactive protein as a screening test for cardiovascular risk in a multiethnic population.

Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S. Anand SS, et al. Among authors: yusuf s. Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1509-15. doi: 10.1161/01.ATV.0000135845.95890.4e. Epub 2004 Jun 17. Arterioscler Thromb Vasc Biol. 2004. PMID: 15205215

9

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Yusuf S, et al. Lancet. 2004 Sep 11-17;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9. Lancet. 2004. PMID: 15364185

10

Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.

Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-amorn C, Sato H, Yusuf S; INTERHEART investigators. Rosengren A, et al. Among authors: yusuf s. Lancet. 2004 Sep 11-17;364(9438):953-62. doi: 10.1016/S0140-6736(04)17019-0. Lancet. 2004. PMID: 15364186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,957 results

Search Page